FRI0186 Retention of First-Line anti-TNF Treatments and in Cases of Failure Retention Rates of anti-TNF Drug or A Non-TNF-Targeted Biologic in A Monocentric Cohort of 200 Rheumatoid Arthritis Patients
FRI0186 Retention of First-Line anti-TNF Treatments and in Cases of Failure Retention Rates of anti-TNF Drug or A Non-TNF-Targeted Biologic in A Monocentric Cohort of 200 Rheumatoid Arthritis Patients